♫musicjinni

Overview of Immune Dysregulation in Autism – M. Leboyer, Université Paris Est Créteil @Synchrony2020

video thumbnail
Marion Leboyer, M.D., Ph.D. is Professor of Psychiatry at the University of Paris Est (UPEC) in Créteil, France. She is head of the University-affiliated department of Psychiatry (Hôpitaux Universitaires Mondor, Assistance-Publique-Hôpitaux de Paris). She also runs the laboratory “Translational Psychiatry” (http://www.imrb.inserm.fr/equipes/m-leboyer-s-jamain/) which is part of Mondor Institute (Inserm U955).

Since 2007, she is the executive director of a non profit foundation, “Fondation FondaMental” (www.fondation-fondamental.org) created by the French Ministry of Research. Dr. Leboyer has authored or co-authored 480 peer-reviewed international publications (H-factor = 73) on autism spectrum disorder and major affective and psychotic disorder.

Her research efforts contributed to a better identification of genetic and environmental risk factors associated with major psychiatric disorders towards better understanding of causal mechanisms. In particular, she has contributed to the identification of mutations of genes implicated in synaptogenesis in autism, associations of genetic vulnerability factors in bipolar disorders, discovery of immune dysfunctions, environmental risk factors as well as brain imaging abnormalities.

Her goal is to develop diagnostic tools to better identify homogenous subgroups of psychiatric disorders paving the way to mechanisms-based treatments. Within the expert center networks centers created and coordinated by Fondation FondaMental, several cohorts of patients have been followed allowing for the construction of shared observational databases. These networks have enabled multiple collaborations within different national and international research programs.

Dr Leboyer is the principal investigator of several international and national research projects funded by the National Research Agency and by the French Ministry of Health.


#psychiatry #psychiatric #neuroimmune #neuropsychiatric #diagnostics


This talk was part of Synchrony 2020 Online Symposium - 'From Bench to Biopharma', organised in partnership with UC Davis MIND Institute and CalTech. For more Synchrony 2020 talks: https://www.youtube.com/playlist?list=PLDtO9h17tcWcRGZHOgtNG9YMJ7BJkO6VR


🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care. To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.

Longitudinal Study of GI Treatment in Autism ASD - Arthur Krigsman, MD @Synchrony2020

Panel Discussion: New Autism Spectrum Disorder ASD Therapeutics in Development @Synchrony 2020

Watch Synchrony 2023 Recordings & Earn CME Credits with The Pathways - ASD Translational Research

Biometric-Guided TMS for Kleefstra Syndrome and ASD - Erik Won, Wave Neuro @Synchrony2021

Synchrony 2023 Talk TRAILER: EEG Past, Present & Future - Implications for Autism, John Gaitanis MD

Synchrony 2023 talk TRAILER: Transcranial Photobiomodulation for Autism - Luis De Taboada

Synchrony 2020 HIGHLIGHTS: 'From Genes to Novel Therapeutics in Autism' - Joseph Buxbaum PhD

From Rare Mutations to Common Treatments in Autism - M. Lalli PhD, Icahn School of Med. @Synchrony22

Research and Innovation in ASD - Session Chair Remarks – John Rodakis MBA @Synchrony2020

Synchrony 2023 talk TRAILER: Microbiota Transplant Therapy for Autism, J.Adams & K.Nirmalkar PhD

Save the Date: Translational Research in Autism - Synchrony Symposium - July 12-14, Asilomar CA

Synchrony 2023 talk TRAILER: Modeling Autism with Human Brain Organoids - Alysson Muotri PhD

Developing Autism Therapeutic Agents - Kevin Sanders MD, Roche/Genentech @Synchrony2020

Synchrony 2023 Talk TRAILER: Testing New Interventions in Autism - Jeremy Veenstra-VanderWeele MD

Safety, Tolerability & Efficacy of AB-2004 in ASD - S Campbell PhD, Axial Therapeutcs @Synchrony2020

Richard Frye, MD, PhD- Synchrony 2019

Assessments in ASD Clinical Trials during COVID - Lisa Nowinski PhD, Harvard @Synchrony2020

Novel Therapeutics for Neurobehavioral Aspects of ASD – S Lipton, MD PhD, Scripps @Synchrony2020

Update on Mitochondrial Research in Autism - Richard Frye, MD @Synchrony 2021

Opportunities for the Advancement of ASD – Diane Stephenson PhD, C-Path Institute @Synchrony2020

Enabling Precision Medicine Drug Development for ASD - Stalicla @Synchrony2020

James Adams, PhD & Rosa Krajmalnik Brown, PhD- Synchrony 2019

Understanding & Treating Autism: Neuroarcheology Concept - Y Ben Ari PhD, Neurochlore @Synchrony2020

Measurement of Restricted and Repetitive Behaviors in ASD – Julian Tillman PhD, Roche @Synchrony2020

Neuromodulation as Component of Treatment Program for ASD – K Shapiro MD PhD, Cortica @Synchrony2020

Synthesizing the ASD Microbiome Field - Robert Mills @Synchrony2022

Synchrony 2023 Talk TRAILER: Using Vagus Nerve Stimulation Therapy for Autism - Crystal Engineer PhD

Glimpses of Synchrony 2019

Synchrony 2023 Talk TRAILER: From 'Chasing My Cure' to Every Cure Repurposing Existing Drugs for ASD

Edward Quadros, PhD- Synchrony 2019

Disclaimer DMCA